Research Gaps: Pediatrics & Behavioral Health/Psychology

Overview

1. Integrated Behavioral Health in Pediatric Primary Care

• Most studies assess short-term behavioral symptom scores, not developmental trajectories or health-system utilization over years.
• Fidelity metrics for "true" integration (vs. simple co-location) are poorly defined.
• Reimbursement and workforce models are rarely studied alongside clinical outcomes.

"Effectiveness of integrated behavioral health models in pediatric primary care on mental health outcomes, emergency utilization, and care access: a systematic review and meta-analysis"

2. Psychological Impact of Pediatric Chronic Illness

• Bidirectional relationships (how mental health worsens disease control, and vice versa) are poorly quantified in children.
• Most RCTs of psychological interventions in chronic illness exclude children under 8 and those with cognitive differences.
• The 2026 systematic review on childhood multimorbidity (PMID: 41703588) noted wide heterogeneity in definitions, making cross-study comparisons nearly impossible.

"Prevalence and severity of anxiety and depressive disorders in children with chronic physical illness compared to healthy peers: a meta-analysis stratified by disease category, age group, and country income level"

3. Adverse Childhood Experiences (ACEs) and Neurodevelopmental Outcomes

• Most ACE research uses retrospective self-report; prospective biomarker studies in children are scarce.
• Few studies examine protective factors (resilience, positive childhood experiences - PCEs) that moderate ACE effects at a neurobiological level.
• Dose-response relationships between ACE subtypes (neglect vs. abuse vs. household dysfunction) and specific diagnostic outcomes lack systematic quantification.

"Dose-response relationship between adverse childhood experiences and neurodevelopmental/psychiatric diagnoses in childhood: a systematic review and meta-analysis of prospective cohort studies"

4. Mental Health in Children with Neurodevelopmental Disorders (NDD)

• The 2024 meta-analysis (PMID: 38757186) on mental health care for autistic children found significant heterogeneity in intervention approaches and a lack of RCTs targeting co-occurring anxiety and depression specifically.
• The 2025 umbrella review on ADHD interventions (PMID: 41297970) called for better data on children under 6 and those with intellectual comorbidity.
• Culturally adapted interventions for NDD children from ethnic minority or LMIC backgrounds are nearly absent from the literature.

"Psychological interventions for anxiety and depression in children with autism spectrum disorder or intellectual disability: a systematic review and network meta-analysis of adapted versus standard CBT"

5. Health Equity and Racial/Ethnic Disparities in Pediatric Mental Health Care

• State-level variation in mental health care access for children is large but poorly explained (race, insurance type, provider availability interact in unstudied ways).
• School-based mental health programs reach underserved populations but have inconsistent evidence on retention and outcomes by demographic subgroup.
• The 2025 Springer study on school-based mental health gaps found Black children disproportionately drop out of treatment, but mechanistic reasons and intervention solutions are understudied.

"Racial, ethnic, and socioeconomic disparities in access to and outcomes of pediatric behavioral health services: a systematic review of US and international evidence"

6. Perinatal and Early Childhood Mental Health (0-5 Years)

• Diagnostic frameworks for mental health in infants and toddlers (e.g., DC:0-5) remain underused in pediatric settings.
• Paternal mental health screening tools are poorly validated (PMID: 38983254 identified major screening gaps).
• Interventions targeting the parent-infant dyad (attachment-based, dyadic therapy) lack large-scale RCTs in diverse populations.
• Long-term follow-up beyond 2 years post-intervention is almost never done.

"Early dyadic/attachment-based interventions (0-3 years) for infant and toddler social-emotional development: a systematic review and meta-analysis of long-term outcomes"

7. Digital and AI-Based Behavioral Health Interventions for Children

• The 2025 narrative review in Children (MDPI) identified complete absence of developmental validation studies - i.e., no rigorous research on how children at different cognitive stages interact with or benefit from AI chatbots.
• Ethical frameworks for AI in pediatric mental health (consent, privacy, parasocial attachment risk) are underdeveloped.
• No longitudinal RCT has examined digital mental health tools exclusively in children under 12.

"Efficacy and safety of digital/app-based behavioral health interventions in children and adolescents: a systematic review with meta-analysis stratified by age group and intervention modality"

8. Pediatric Pain, Somatization, and Psychosocial Factors

• Psychological treatments (CBT, hypnosis, biofeedback) for pediatric chronic pain show promise but studies are small, short-term, and methodologically heterogeneous.
• The role of parental psychological functioning in perpetuating vs. buffering child somatic symptoms is understudied.
• Transition from pediatric to adult care for somatic symptom disorders has no evidence base.

"Psychological interventions for pediatric functional somatic symptom disorders: a systematic review and meta-analysis of CBT, hypnosis, and biofeedback RCTs"

9. Global/Cross-National Research Equity in Adolescent Mental Health

• Clinical presentation, help-seeking, and treatment response vary by culture but most instruments are not cross-culturally validated for children.
• LMIC burden estimates for pediatric behavioral disorders rely almost entirely on extrapolation.

"Prevalence of depression, anxiety, and behavioral disorders in children and adolescents in low- and middle-income countries: a systematic review and meta-analysis with geographic equity analysis"

10. Pediatric Psychopharmacology: Long-Term Safety and Developmental Effects

• Most pediatric drug trials are 8-12 weeks; effects on pubertal development, brain structure, and adult mental health trajectories are largely unknown.
• The 2025 umbrella review on ADHD interventions (BMJ, PMID: 41297970) explicitly called for better long-term safety data in children.
• Ethnic and sex-based pharmacokinetic differences in children are rarely reported.

"Long-term neurodevelopmental and psychiatric outcomes of stimulant and SSRI use initiated in childhood: a systematic review and meta-analysis of observational studies with minimum 5-year follow-up"

Summary Table: Meta-Analysis/SR Topics at a Glance

Research Gaps: Child Psychiatry & Behavioral Health/Psychology

Framing the Problem

1. Early Detection and Prediction of Psychiatric Disorders in Children

• The 2024 meta-analysis on individualized prediction models in ADHD (PMID: 38783054) found that machine learning models show promise but suffer from small sample sizes, lack of external validation, and heterogeneous predictor sets - none are clinically deployable.
• The 2024 meta-analysis on immune/oxidative stress biomarkers in pediatric psychosis (PMID: 38141839) identified inflammatory signals in at-risk youth but no validated biomarker panel exists for early detection.
• Neuroimaging, genetic, and behavioral data exist in silos; multi-modal prediction models are almost entirely absent for children under 12.

"Accuracy of clinical, neuroimaging, and biological biomarkers for early identification of children at high risk for psychosis, bipolar disorder, and severe anxiety: a systematic review and meta-analysis of prospective studies"

2. Very Early-Onset Schizophrenia and Childhood-Onset Psychosis

• Antipsychotic safety and dosing data in children under 13 are almost entirely absent.
• Psychosocial interventions (family therapy, cognitive remediation, supported education) have never been formally tested via RCT in this age group.
• Long-term developmental and cognitive trajectories after childhood-onset psychosis are unknown.

"Pharmacological and psychosocial interventions for very early-onset schizophrenia (onset <13 years): a systematic review of efficacy, tolerability, and neurodevelopmental outcomes"

3. Trauma, Complex PTSD, and Childhood Maltreatment

• The 2026 GBD analysis (Lancet, PMID: 41386261) quantified the global disease burden of sexual violence against children across 204 countries, but intervention research matching that scale does not exist.
• Trauma-Focused CBT (TF-CBT) has reasonable evidence, but its effectiveness in children with co-occurring neurodevelopmental disorders, dissociative symptoms, or complex/repeated trauma is unknown.
• EMDR, somatic therapies, and play therapy are used widely in children but lack high-quality RCT evidence, particularly for pre-school age groups.
• C-PTSD as a distinct diagnosis (ICD-11) in children has almost no dedicated treatment literature.

"Comparative effectiveness of trauma-focused psychological therapies (TF-CBT, EMDR, play therapy, somatic approaches) for childhood PTSD and C-PTSD: a network meta-analysis of RCTs stratified by trauma type and developmental stage"

4. Pediatric Suicide, Self-Harm, and Non-Suicidal Self-Injury (NSSI)

• The 2025 JAMA Pediatrics meta-analysis on safety planning (PMID: 40388177) found safety planning interventions reduce suicidal ideation, but evidence for completed suicide prevention is absent - it is effectively an unmeasured outcome in most trials.
• The 2025 Lancet Psychiatry meta-analysis on family dynamics and self-harm (PMID: 40812960) confirmed family dysfunction as a risk factor, but family-based interventions for suicidality remain understudied.
• The 2026 meta-analysis on DBT for adolescents (PMID: 39565348) showed clinical benefit but noted wide implementation variability and near-complete absence of data for children under 14.
• Suicide risk among children under 10 - a growing concern - is virtually unaddressed in the research literature.

"Effectiveness of pharmacological, psychological, and safety-planning interventions for suicidal ideation and self-harm in children and early adolescents (ages 8-14): a systematic review and meta-analysis"

5. Measurement-Based Care and Outcome Monitoring in Child Psychiatric Settings

• The 2024 systematic review on MBC implementation for youth (PMID: 39477858) found MBC improves outcomes when implemented, but barriers (clinician buy-in, age-appropriate tools, multi-informant complexity) are poorly characterized, and which measures are most clinically useful remains unclear.
• Multi-informant disagreement (parent vs. child vs. teacher report) in outcome measurement is a methodological problem unique to child psychiatry that has no satisfactory solution in current practice.
• Routine outcome monitoring in community child psychiatric settings (as opposed to academic research centers) is almost entirely absent from the evidence base.

"Impact of measurement-based care implementation on treatment outcomes in child and adolescent psychiatric settings: a systematic review and meta-analysis of controlled studies"

6. Adolescent Personality Pathology and Borderline Personality Disorder (BPD)

• Most BPD treatment trials (DBT, MBT) exclude patients under 18 or treat adolescents as an afterthought subgroup.
• The question of whether BPD in adolescence represents a stable trait or a developmental phase is unresolved - with major implications for diagnosis, labeling, and treatment decisions.
• The interaction between adolescent BPD and co-occurring eating disorders, substance use, and ADHD is poorly characterized.
• The 2025 Lancet Psychiatry global epidemiology of personality disorder (PMID: 41197646) identified severe data gaps for adolescent populations globally.

"Efficacy and long-term outcomes of dialectical behavior therapy and mentalization-based therapy for adolescents with borderline personality features: a systematic review and meta-analysis"

7. Pediatric Bipolar Spectrum Disorder - Diagnosis, Phenotype, and Treatment

• Mood dysregulation in children can stem from multiple etiologies (ADHD, trauma, temperament, emerging BPD, disruptive mood dysregulation disorder) that are phenomenologically similar but diagnostically distinct.
• Most pharmacological trials for pBD exclude children under 10, have industry sponsorship bias, and use short (8-12 week) endpoints.
• Psychological interventions (family-focused therapy, RAINBOW, IPSRT-A for adolescents) have small evidence bases with no multi-site RCTs.
• Long-term (>2 year) treatment outcome data in pBD are nearly nonexistent.

"Pharmacological and psychological treatments for pediatric bipolar spectrum disorder: a systematic review and network meta-analysis of short- and long-term outcomes across age groups"

8. Eating Disorders in Children and Young Adolescents

• ARFID (Avoidant/Restrictive Food Intake Disorder) was only formally recognized in DSM-5 (2013). Evidence-based treatments for ARFID in children are sparse; CBT-ARFID trials only began in the past 5 years.
• Family-Based Treatment (FBT/Maudsley) has good evidence for adolescent AN but almost no evidence for children under 11 or for boys.
• The interaction between eating disorder psychopathology and autism spectrum disorder in girls is becoming clinically prominent but lacks systematic study.
• Medical-psychiatric interface issues (refeeding syndrome management, inpatient vs. outpatient decision-making) have no strong evidence base.

"Psychological and family-based interventions for avoidant/restrictive food intake disorder (ARFID) in children and adolescents: a systematic review and meta-analysis of treatment outcomes"

9. Child and Adolescent Psychiatric Care in Low- and Middle-Income Countries (LMICs)

• The diagnostic validity of Western psychiatric constructs (DSM/ICD) in non-Western cultural contexts is poorly tested in children.
• Community health worker-delivered mental health interventions for children have very few RCTs and almost no data on fidelity, dose-response, or long-term outcomes.
• Stigma as a barrier to care-seeking for child psychiatric illness in LMIC contexts is recognized but rarely measured as a primary outcome variable.

"Effectiveness of task-shifted and community-based interventions for child and adolescent psychiatric disorders in low- and middle-income countries: a systematic review and meta-analysis"

10. School-Based Mental Health and the Psychiatry-Education Interface

• The 2024 Cochrane review on suicide/self-harm prevention in education settings (PMID: 39704320) found insufficient high-quality evidence for school programs, particularly for children under 14.
• Universal social-emotional learning (SEL) programs and selective indicated programs for at-risk youth differ widely in implementation fidelity, with no consensus on which components are active ingredients.
• The pathway from school-based identification to formal psychiatric assessment and treatment is fragmented - with no RCT examining the outcome of different referral pathways.
• Gender and LGBTQ+ specific needs within school mental health programs are under-researched.

"School-based indicated mental health interventions for children with emerging psychiatric symptoms: a systematic review and meta-analysis of academic, behavioral, and clinical outcomes"

11. Psychopharmacology in Child Psychiatry - Off-Label Use and Long-Term Effects

• Antipsychotic prescribing to children for behavioral indications (not psychosis) has grown dramatically, yet long-term metabolic, endocrine, and neurodevelopmental safety data are scarce.
• The 2025 umbrella review on ADHD interventions (Lancet/BMJ, PMID: 41297970) explicitly flagged the absence of long-term safety data for stimulant use in children under 6.
• Sex and pubertal stage effects on pharmacokinetics and drug response in children are almost entirely absent from the literature.
• Polypharmacy in youth with complex presentations (ASD + ADHD + anxiety + sleep disorder, for example) has no evidence base at all.

"Long-term metabolic, neurodevelopmental, and psychiatric safety of antipsychotic use initiated in childhood and adolescence: a systematic review and meta-analysis of observational cohort studies with minimum 3-year follow-up"

12. The Role of the Parent-Child Relationship in Child Psychiatric Treatment

• Parent management training (PMT) has a reasonable evidence base for externalizing disorders (ADHD, ODD, CD) but is rarely integrated into treatment plans for internalizing disorders (depression, anxiety, trauma) in children.
• The psychiatric/psychological wellbeing of the parent as a mediator of child treatment outcomes is largely unmeasured in clinical trials.
• Attachment-based interventions for school-age children with psychiatric diagnoses (as opposed to infants/toddlers) have very little RCT evidence.

"Parent-inclusive psychosocial interventions for child psychiatric disorders (ages 5-12): a systematic review and meta-analysis comparing child-only vs. parent-involved treatment approaches on child and parent outcomes"

Summary Table

Cross-Cutting Themes

• Developmental specificity: Most psychiatric studies treat "children and adolescents" as a homogeneous group, ignoring the vast neurodevelopmental differences between a 5-year-old and a 17-year-old.
• Multi-informant complexity: No pediatric psychiatric outcome measure has resolved the measurement challenge of integrating parent, child, teacher, and clinician perspectives.
• Diversity and representation: Trials are overwhelmingly white, English-speaking, and from high-income settings - limiting generalizability.
• Longitudinal follow-up: The field is dominated by 8-16 week trials; the developmental consequences of both treatment and non-treatment over years are largely unknown.
• Comorbidity: Most trials exclude complex comorbid presentations, yet these represent the majority of children seen in real clinical settings.